Solventum Corp reported $403M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Abbott USD 6.8B 1.72B Mar/2026
Align Technology USD 1.1B 42.76M Jun/2026
Baxter International USD 2.15B 133M Jun/2026
Becton, Dickinson and Co. USD 708M 105M Jun/2026
Cencora USD 2.18B 423.37M Mar/2026
Dexcom USD 1.1B 13.2M Jun/2026
Insulet USD 534.9M 54.5M Jun/2026
Solventum Corp USD 403M 158M Jun/2026
West Pharmaceutical Services USD 435.8M 85.6M Jun/2026
Zimmer Biomet Holdings USD 410M 14.2M Jun/2026